Apogee (NASDAQ: APOG) director receives deferred stock unit award

Rhea-AI Filing Summary

Lilly Elizabeth Murphy reported acquisition or exercise transactions in this Form 4 filing.

Apogee Enterprises director Elizabeth Murphy received a routine equity grant in the form of deferred restricted stock units. She was awarded 55 deferred units tied to Apogee common stock at a reference value of $33.54 per unit, increasing her direct holdings of these units to 6,900.

The units were granted under Apogee’s 2019 Non-Employee Director Stock Plan and include additional allocations from a dividend equivalent reinvestment feature. Each unit is settled 1-for-1 in common shares after she leaves the Board or upon other events specified in the plan, so this filing reflects compensation rather than an open-market share purchase.

Insights

Equity compensation analyst

Routine director equity grant via deferred stock units, not an open-market buy.

Director Elizabeth Murphy received 55 deferred restricted stock units linked to Apogee Enterprises common stock, bringing her total to 6,900 units. The award falls under the 2019 Non-Employee Director Stock Plan and represents standard board compensation.

The filing notes 1-for-1 settlement into common shares and includes units added through a dividend equivalent reinvestment feature, which credits additional units when dividends are paid. Because this is a grant (code A) rather than a market purchase or sale, it carries limited signaling value for short-term stock expectations.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lilly Elizabeth Murphy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units	55	$33.54	$2K

Holdings After Transaction: Deferred Restricted Stock Units — 6,900 shares (Direct)

Footnotes (1)

1. Settled 1-for-1. Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Key Figures

Deferred RSUs granted: 55 units Reference price per unit: $33.54 per unit Deferred RSUs after grant: 6,900 units +1 more

4 metrics

Deferred RSUs granted 55 units Grant of deferred restricted stock units on 2026-03-31

Reference price per unit $33.54 per unit Valuation reference for deferred restricted stock unit grant

Deferred RSUs after grant 6,900 units Total deferred restricted stock units following transaction

Underlying common stock 55 shares Shares of common stock underlying new deferred units

Key Terms

Deferred Restricted Stock Units, dividend equivalent reinvestment feature, 2019 Non-Employee Director Stock Plan, Grant, award, or other acquisition, +1 more

5 terms

Deferred Restricted Stock Units financial

"security_title: "Deferred Restricted Stock Units""

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

dividend equivalent reinvestment feature financial

"allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan"

2019 Non-Employee Director Stock Plan financial

"allocated under the 2019 Non-Employee Director Stock Plan"

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

settled in shares of common stock financial

"will be settled in shares of common stock following the director's termination from the Board"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lilly Elizabeth Murphy

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MINNESOTA 55435

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(1)	03/31/2026		A(2)		55		(3)	(3)	Common Stock	55	$33.54	6,900	D

Explanation of Responses:

1. Settled 1-for-1.

2. Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

3. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Remarks:

	/s/ David Wright Walstrom Attorney-in-Fact for Elizabeth Murphy Lilly	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Apogee (APOG) director Elizabeth Murphy report in this Form 4?

Elizabeth Murphy reported receiving 55 deferred restricted stock units as a compensation grant. These units, tied 1-for-1 to Apogee common stock, raised her deferred unit holdings to 6,900, reflecting routine non-employee director equity compensation rather than an open-market share purchase.

How many Apogee (APOG) deferred restricted stock units does Elizabeth Murphy hold after this grant?

After the grant, Elizabeth Murphy holds 6,900 deferred restricted stock units. The Form 4 shows that 55 new units were awarded, increasing her position, with each unit linked to one share of Apogee common stock under the 2019 Non-Employee Director Stock Plan.

Is Elizabeth Murphy’s Apogee (APOG) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant, not a stock purchase. The transaction code is A, indicating a grant or award of 55 deferred restricted stock units under Apogee’s director stock plan, classified as equity compensation rather than an open-market buy in the company’s shares.

When will Elizabeth Murphy’s Apogee (APOG) deferred stock units be settled into common shares?

The deferred restricted stock units will be settled in common shares after Elizabeth Murphy’s termination from the Board, or upon other events specified in the 2019 Non-Employee Director Stock Plan, consistent with her prior election regarding timing of settlement for these long-term equity awards.

What is the role of dividend equivalents in Elizabeth Murphy’s Apogee (APOG) deferred stock units?

Some units were added through a dividend equivalent reinvestment feature in the 2019 Non-Employee Director Stock Plan. When Apogee pays dividends, this feature credits additional deferred restricted stock units, effectively reinvesting dividend value into more units instead of paying cash dividends directly.